lilly glp 1 drug As GLP-1 Use Expands, Long-Term Safety Questions Remain Under Watch America has a new weight-loss

Under her leadership, the medical spa coordinates wellness-focused care with her background in cosmetic injectables, recognizing that significant weight change can affect facial structure, skin quality, and aesthetic planning within a single physician-directed setting

September 4, 2025: Texas AG Files Lawsuit Against Eli Lilly for Zepbound Prescribing Practices The Attorney General of Texas has sued Zepbound manufacturer Eli Lilly, accusing the company of using illegal practices to boost sales

Florida Blue, UHC, Medicare & Oscar Insurance companies use different medical policies when reviewing GLP-1 medications, bariatric surgery, and post-weight-loss procedures

Mol Med 24(1):3 Zhang Z, Sun M, Jiang W, Yu L, Zhang C, Ma H (2024) Myocardial metabolic reprogramming in HFpEF

This shift can lead to better adherence and sustained engagement with care plans